188 related articles for article (PubMed ID: 27448703)
1. Twenty-four months of follow-up of a "biodegradable" model for coronary artery bifurcation management. Insights from optical coherence tomography of a new interventional strategy.
Buccheri D; Cortese B
Int J Cardiol; 2016 Nov; 222():37-38. PubMed ID: 27448703
[No Abstract] [Full Text] [Related]
2. Treading the risky ground of coronary bifurcation lesion revascularization, the "biodegradable strategy" may represent the lifeline.
Piraino D; Buccheri D; Andolina G
Int J Cardiol; 2016 Oct; 221():577-80. PubMed ID: 27420582
[No Abstract] [Full Text] [Related]
3. Severe Neointimal Hyperplasia of Neoplastic Carina Following Bioresorbable Scaffold Implantation Using T-Stenting and Small Protrusion Technique: Insights From Optical Frequency Domain Imaging.
Kawamoto H; Ruparelia N; Figini F; Latib A; Colombo A
JACC Cardiovasc Interv; 2015 Nov; 8(13):e207-9. PubMed ID: 26476605
[No Abstract] [Full Text] [Related]
4. Step by step, the description of the "biodegradable" strategy for the treatment of coronary bifurcation lesions.
Piraino D; Cimino G; Andolina G
Int J Cardiol; 2016 Nov; 223():37-39. PubMed ID: 27529587
[No Abstract] [Full Text] [Related]
5. The Absorb Limits.
Gómez Menchero AE; Camacho Freire SJ; Díaz Fernández JF; Roa Garrido J; León Jiménez J; Cardenal Piris R
J Invasive Cardiol; 2016 Oct; 28(10):E122-E123. PubMed ID: 27705895
[TBL] [Abstract][Full Text] [Related]
6. Drug-coated balloon for recurrent in-stent restenosis treatment: A suitable strategy.
Piraino D; Buccheri D; Cimino G; Andolina G
Int J Cardiol; 2016 Oct; 221():1084-6. PubMed ID: 27448537
[No Abstract] [Full Text] [Related]
7. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM
Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057
[TBL] [Abstract][Full Text] [Related]
8. First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.
Latini RA; Buccheri D; Cortese B
Catheter Cardiovasc Interv; 2017 Mar; 89(4):676-678. PubMed ID: 27649683
[TBL] [Abstract][Full Text] [Related]
9. Treatment of coronary stent restenosis with drug-eluting bioabsorbable magnesium scaffolds.
Alfonso F; Cuesta J; García-Guimaraes M; Bastante T; Maruri R; Rivero F
Coron Artery Dis; 2017 Nov; 28(7):627-628. PubMed ID: 28644215
[No Abstract] [Full Text] [Related]
10. Optical coherence tomography of a bifurcation lesion treated with bioresorbable vascular scaffolds with the "mini-crush" technique.
Costopoulos C; Naganuma T; Latib A; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1326-7. PubMed ID: 24355123
[No Abstract] [Full Text] [Related]
11. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
[No Abstract] [Full Text] [Related]
12. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
[TBL] [Abstract][Full Text] [Related]
13. Two-Year Follow-Up OCT Images of 2 Bifurcation Lesions Treated With Bioresorbable Vascular Scaffolds.
Kawamoto H; Panoulas VF; Sato K; Miyazaki T; Latib A; Colombo A
JACC Cardiovasc Imaging; 2015 May; 8(5):617-618. PubMed ID: 25457765
[No Abstract] [Full Text] [Related]
14. First-in-man unprotected left main stenting with Stentys Xposition S self-apposing sirolimus eluting stent and optical coherence tomography guidance: The emerging panacea for left main intervention.
Yew KL; Kang Z
Int J Cardiol; 2015 Dec; 201():628-30. PubMed ID: 26340130
[No Abstract] [Full Text] [Related]
15. Coregistered intravascular ultrasound and optical coherence tomography imaging during implantation of a bioresorbable vascular scaffold.
Brown AJ; McCormick LM; Hoole SP; West NE
JACC Cardiovasc Interv; 2013 Jul; 6(7):e41-2. PubMed ID: 23866193
[No Abstract] [Full Text] [Related]
16. Optical coherence tomography: a new tool to detect tissue coverage in drug-eluting stents.
Di Mario C; Barlis P
JACC Cardiovasc Interv; 2008 Apr; 1(2):174-5. PubMed ID: 19463296
[No Abstract] [Full Text] [Related]
17. Novel fully bioabsorbable salicylate-based sirolimus-eluting stent.
Jabara R; Pendyala L; Geva S; Chen J; Chronos N; Robinson K
EuroIntervention; 2009 Dec; 5 Suppl F():F58-64. PubMed ID: 22100678
[TBL] [Abstract][Full Text] [Related]
18. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
[TBL] [Abstract][Full Text] [Related]
19. Extremely Late Catch-Up Phenomenon After First-Generation Sirolimus-Eluting Stent in the Left Main Stem: Insights From Optical Coherence Tomography.
Naganuma T; Fujino Y; Tahara S; Mitomo S; Basavarajaiah S; Nakamura S
JACC Cardiovasc Interv; 2015 Dec; 8(14):e237-9. PubMed ID: 26718525
[No Abstract] [Full Text] [Related]
20. The artery under the lens.
Prati F; Ramazzotti V
EuroIntervention; 2010 May; 6(1):15-7. PubMed ID: 20542791
[No Abstract] [Full Text] [Related]
[Next] [New Search]
